Effect of the mGlu 2 positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmoset
European Journal of Neuroscience · 2024
DOI: 10.1111/ejn.16454 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neuroscience, 2024. Verfasst von Woojin Kang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neurodegenerative Disorders Research Group, Montreal Neurological Institute-Hospital (The Neuro), Montreal, QC, Canada. Hauptthemen laut MEDLINE: Callithrix, Levodopa, Receptors, Metabotropic Glutamate, Antiparkinson Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michael J. Fox Foundation for Parkinson's Research, Parkinson Canada, Fonds de Recherche du Québec - Santé.
Abstract (Originalsprache)
Activation of metabotropic glutamate 2 (mGlu 2 ) receptors is a potential novel therapeutic approach for the treatment of parkinsonism. Thus, when administered as monotherapy or as adjunct to a low dose of L‐3,4‐dihydroxyphenylalanine (L‐DOPA), the mGlu 2 positive allosteric modulator (PAM) LY‐487,379 alleviated parkinsonism in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primates. Here, we sought to investigate the effect of biphenyl‐indanone A (BINA), a highly selective mGlu 2 PAM whose chemical scaffold is unrelated to LY‐487,379, to determine if a structurally different mGlu 2 PAM would also confer anti‐parkinsonian benefit. In monotherapy experiments, MPTP‐lesioned marmosets were injected with either vehicle, L‐DOPA/benserazide (15/3.75 mg/kg, positive control) or BINA (0.1, 1, 10 mg/kg). In adjunct to a low L‐DOPA dose experiments, MPTP‐lesioned marmosets were injected with L‐DOPA/benserazide (7.5/1.875 mg/kg) in combination with vehicle or BINA (0.1, 1, 10 mg/kg). Parkinsonism, dyskinesia and psychosis‐like behaviours (PLBs) were then quantified. When administered alone, BINA 1 and 10 mg/kg decreased parkinsonism severity by ~22% ( p < 0.01) and ~47% ( p < 0.001), when compared with vehicle, which was comparable with the global effect of a high L‐DOPA dose. When administered in combination with a low L‐DOPA dose, BINA 1 and 10 mg/kg decreased global parkinsonism by ~38% ( p < 0.001) and ~53% ( p < 0.001). BINA 10 mg/kg decreased global dyskinesia by ~94% ( p < 0.01) and global PLBs by ~92% ( p < 0.01). Our results provide additional evidence that mGlu 2 positive allosteric modulation elicits anti‐parkinsonian effects. That this benefit is not related to a particular chemical scaffold suggests that it may be a class effect rather than the effect of a specific molecule.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurodegenerative Disorders Research Group, Montreal Neurological Institute-Hospital (The Neuro), Montreal, QC, Canada.
- Département de Pharmacologie et Physiologie, Université de Montréal, Montreal, QC, Canada.
- Comparative Medicine & Animal Resource Centre, McGill University, Montreal, QC, Canada.
- Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.
- Department of Neurosciences, McGill University Health Centre, Montreal, QC, Canada.
ORCID-Profile: Adjia Hamadjida, Philippe Huot
Förderung
- Michael J. Fox Foundation for Parkinson's Research
- Parkinson Canada
- Fonds de Recherche du Québec - Santé
- Weston Brain Institute
- Natural Sciences and Engineering Research Council of Canada
- New Frontiers in Research Fund
- CIHR
- Healthy Brains for Healthy Lives
Zitieren
APA
Kang, W., Frouni, I., Kwan, C., Bédard, D., Nuara, S. G., Hamadjida, A., Gourdon, J. C., & Huot, P. (2024). Effect of the mGlu 2 positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmoset. European Journal of Neuroscience. https://doi.org/10.1111/ejn.16454
Vancouver
Kang W, Frouni I, Kwan C, Bédard D, Nuara SG, Hamadjida A, et al. Effect of the mGlu 2 positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmoset. European Journal of Neuroscience. 2024. doi:10.1111/ejn.16454
BibTeX
@article{Kang2024,
author = {Kang, Woojin and Frouni, Imane and Kwan, Cynthia and Bédard, Dominique and Nuara, Stephen G and Hamadjida, Adjia and Gourdon, Jim C and Huot, Philippe},
title = {Effect of the mGlu 2 positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmoset},
journal = {European Journal of Neuroscience},
year = {2024},
doi = {10.1111/ejn.16454}
}
EUVIMED